Clinical Efficacy First

Precision mapping.
Targeted protocols.

We deploy 19-channel quantitative EEG (QEEG) to identify network dysregulation, followed by operant conditioning protocols to normalise cortical activity.

Explore QEEG Mapping View Clinical Data

Figure 1.0 19-Channel Normative Database Comparison

Clinical Focus Areas

Attention Regulation

Theta/Beta Ratio Protocol

Targeting the central midline (Cz) to down-train excess Theta (4-8 Hz) and up-train low Beta (12-15 Hz) or SMR. Clinical data indicates significant improvements in sustained attention.

→ View ADHD Protocol Data

Anxiety & Hyperarousal

Alpha Symmetry Protocol

Addressing right frontal Alpha asymmetry. By encouraging greater Alpha amplitude in the right hemisphere relative to the left, we observe a reduction in somatic anxiety.

→ View Anxiety Protocol Data

Trauma & Dysregulation

Infra-Low Frequency (ILF)

Targeting extremely slow cortical potentials (< 0.1 Hz) to stabilise the autonomic nervous system. Particularly indicated for severe hyper-arousal and PTSD.

→ View ILF Trauma Data

The Mapping Protocol

Phase 01

Data Acquisition

A 19-channel electro-cap is applied. We record 10 minutes of eyes-open and 10 minutes of eyes-closed resting state EEG data, ensuring impedance remains below 5kΩ.

Phase 02

Artifacting & Analysis

Raw data is manually pruned for muscle (EMG), eye blink (EOG), and movement artifacts. The clean data is processed through Fast Fourier Transform (FFT).

Phase 03

Normative Database Comparison

We compare the patient's spectral data against the FDA-registered NeuroGuide database (N=625) to identify statistically significant deviations (Z-scores > +2 or < -2).

Phase 04

Protocol Design

A highly specific operant conditioning protocol is established based on the Z-score deviations, targeting exact Brodmann areas and network hubs.

Observed Clinical Outcomes

Aggregated data from N=340 completed 40-session protocols (2021-2023).

Read Methodology →

Primary Indication	Standard Protocol	Session Count	Symptom Reduction*	Remission Rate
ADHD (Inattentive)	Cz Theta↓ / Beta↑	40	68% (IVA-2 CPQA)	72%
GAD (Anxiety)	PZ Alpha↑ / High-Beta↓	30-40	74% (GAD-7)	81%
Insomnia (Onset)	C4 SMR↑ / High-Beta↓	20-30	65% (ISI)	64%
PTSD	T3/T4 ILF (0.01 Hz)	40+	61% (PCL-5)	58%

* Symptom reduction percentages represent mean score improvements on respective standardized assessments post-treatment. Remission defined as dropping below clinical thresholds.

Specs.01

Mitsar 201

21-channel EEG system with a 500 Hz sampling rate. Exclusively used for our diagnostic QEEG mappings due to exceptional common-mode rejection.

Specs.02

NeuroAmp II

DC-coupled amplifier capable of measuring frequencies down to 0.001 Hz. Utilized for our Infra-Low Frequency (ILF) protocols.

Protocol Efficacy Calculator

Practitioners and prospective patients can use our statistical modeling tool to estimate the required session count and expected symptom reduction based on initial QEEG Z-scores.

Launch Calculator

Scientific Validation

Neurofeedback is not a novel concept; it is supported by decades of peer-reviewed research. Our clinical protocols are strictly aligned with the findings of the ISNR (International Society for Neurofeedback and Research) and the AAPB.

01.

AAPB Efficacy Ratings

ADHD neurofeedback holds a Level 5 (Efficacious and Specific) rating, the highest possible tier for clinical intervention.
02.

fMRI Correlation

Simultaneous EEG-fMRI studies demonstrate that QEEG-guided training produces durable changes in BOLD signal within the default mode network.

Key Citations

Arns, M., et al. (2009). Efficacy of neurofeedback treatment in ADHD. Clinical EEG and Neuroscience.
Micoulaud-Franchi, J. A., et al. (2015). EEG neurofeedback treatments in children with ADHD. Frontiers in Human Neuroscience.
Hammond, D. C. (2005). Neurofeedback with anxiety and affective disorders. Child and Adolescent Psychiatric Clinics.

Board Certification Matters

BCIA

Strict Standards

All practitioners hold Biofeedback Certification International Alliance credentials.

QEEG-D

Diplomate Status

Maps are read by board-certified QEEG Diplomates to prevent misdiagnosis.

3000+

Clinical Hours

Minimum supervised training hours required before independent protocol design.

MD/PhD

Oversight

Multidisciplinary oversight including neuropsychology and psychiatry.

Targeting the Default Mode Network (DMN)

Much of clinical pathology—from rumination in depression to hyper-vigilance in anxiety—stems from a failure to appropriately suppress the Default Mode Network during task-positive states.

By utilizing LORETA (Low Resolution Electromagnetic Tomography) 3D imaging, we can specifically target deep cortical hubs like the Posterior Cingulate Cortex (PCC) and Medial Prefrontal Cortex (mPFC), rewarding the brain for establishing healthy phase lock and shift dynamics between these regions.

Read about LORETA targeting →

The In-Clinic Experience

Preparation

Sensors are applied using conductive paste. The process is painless, non-invasive, and takes less than 5 minutes.

Training

You watch a movie or play a simple video game. The software continuously monitors your EEG and fades the screen or audio when your brain deviates from the target parameter.

Consolidation

Through hundreds of micro-rewards per minute, the cortex implicitly learns the new state. Sessions last 30-45 minutes.

Subjective Reporting

While QEEG provides objective data, patient experience remains paramount. We utilize weekly standardized psychometric scaling (GAD-7, PHQ-9, ASRS) to ensure cortical changes are translating to real-world functional improvements.

Objective Measurement

Every 20 sessions, a follow-up QEEG is recorded. We mathematically compare the mid-treatment map against the baseline to verify Z-score normalization toward the mean.

View Tracking Methodology

Investment & Accessibility

Clinical neurofeedback requires specialized hardware and highly trained personnel. We believe in complete transparency regarding the investment required for true structural change.

Initial QEEG Mapping

Includes recording, artifacting, and 90-minute consultation.

$850

Per Session Rate

45-minute clinical training block.

$175

* Superbills provided for out-of-network insurance reimbursement.

Addressing Clinical Skepticism

Is it just a placebo?

Double-blind, sham-controlled studies have demonstrated that true neurofeedback produces significant cortical changes and symptom reduction that sham (fake) neurofeedback does not, particularly in ADHD populations.

Why isn't it more widely prescribed?

It requires significant time investment (30-40 hours of clinic time) compared to the 15-minute medication management model. It is also heavily operator-dependent; poorly designed protocols yield poor results.

Are the results permanent?

Longitudinal studies indicate that once neuroplastic consolidation occurs (typically after 30-40 sessions), the behavioral and cortical changes are sustained years post-treatment, unlike medication which ceases working when metabolized.

Are there side effects?

When guided by a QEEG, side effects are minimal and transient (e.g., temporary fatigue, mild headache). Without QEEG guidance, training the wrong frequency can temporarily exacerbate symptoms.

Utilizing FDA-Registered Clinical Hardware

Mitsar Medical BrainMaster BEE Medic Applied Neuroscience

Ready to map your baseline?

Stop guessing with subjective diagnoses. Get an objective, mathematical analysis of your cortical function.

Schedule QEEG Assessment

Precision mapping. Targeted protocols.